Omalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study

J Am Acad Dermatol. 2016 Mar;74(3):574-5. doi: 10.1016/j.jaad.2015.11.021.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Omalizumab / therapeutic use*
  • Severity of Illness Index
  • Sunlight / adverse effects
  • Treatment Outcome
  • Urticaria / drug therapy*
  • Urticaria / etiology

Substances

  • Omalizumab